About DCS Pharma
DCS Pharma is a Healthcare company based in Basel (Switzerland) founded in 2016, and was acquired by IMCD in November 2019. Pharmaceutical products are distributed by DCS Pharma in Switzerland. DCS Pharma has completed 1 acquisition, including Chem Sources. Its chief executive, as recorded, is Beat Berger. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Xantis Pharma, RUWAG and Globomedica.
Company details
DCS Pharma was established in 2016 in Basel, Switzerland, as a distributor within the pharmaceutical sector. Operations focus on the supply and distribution of pharmaceutical products to various markets. The company is led by CEO Beat Berger. Services include logistics and regulatory compliance for pharmaceutical goods, with activities centered in Europe. Geographic emphasis remains on Switzerland-based headquarters.
- Headquarters Basel, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dcspharma.com
- Social LinkedIn X
- Acquired by IMCD (Nov 2019)
- Investors
- Investments & Acquisitions
- Acquired byIMCD
(Nov 2019)
Investors in DCS Pharma
DCS Pharma has secured backing from 1 investor. Prominent investors backing the company include IMCD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Speciality chemicals and food ingredients are distributed by IMCD. | 1995 | imcdgroup.com | Rotterdam, Netherlands |
Investor details for DCS Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DCS Pharma
1 people are tracked at DCS Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Beat Berger | CEO | Leadership |
Complete people profiles for DCS Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DCS Pharma
DCS Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chem Sources.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Chemical information is accessed via an online database platform. | chemsource.com | Clemson, United States | 1958 | Feb 2019 | •••• |
Complete acquisition details for DCS Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of DCS Pharma
3 dated milestones of DCS Pharma across 3 years, from founding to its latest funding, stage changes and deals.
- Founded DCS Pharma is founded.
- Acquisition Acquires Chem Sources.
- Exit Acquired by IMCD.
Competitors of DCS Pharma
DCS Pharma has 3 listed competitors in our database. They include Xantis Pharma, RUWAG and Globomedica.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xantispharma.com | 2015 | Zug, Switzerland | Distributor of generic prescription and over-the-counter products | |||
| ruwag.ch | 1987 | Bettlach, Switzerland | Distributor of drugs | |||
| globomedica.ch | 2009 | Egg, Switzerland | Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland. |
Detailed competitors of DCS Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dcs Pharma
Complete news archive for DCS Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DCS Pharma
DCS Pharma was founded in 2016.
DCS Pharma is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Beat Berger is the CEO of DCS Pharma, as recorded in our data.
DCS Pharma was established in 2016 in Basel, Switzerland, as a distributor within the pharmaceutical sector. Operations focus on the supply and distribution of pharmaceutical products to various markets. The company is led by CEO Beat Berger. Services include logistics and regulatory compliance for pharmaceutical goods, with activities centered in Europe. Geographic emphasis remains on Switzerland-based headquarters.
DCS Pharma's top competitors include RUWAG, Globomedica and Xantis Pharma.
DCS Pharma has made 1 acquisition, including Chem Sources.
DCS Pharma has 1 investor. Key investors include IMCD.
Yes. DCS Pharma was acquired by IMCD in November 2019.